# FDA 483 - GlaxoSmithKline dba Human Genome Sciences Inc - April 26, 2013

Source: https://www.keypedia.com/records/483/glaxosmithkline-dba-human-genome-sciences-inc/928ba880-1b8c-4356-831e-0f16d2c1f4dd

> FDA 483 for GlaxoSmithKline dba Human Genome Sciences Inc on April 26, 2013. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: GlaxoSmithKline dba Human Genome Sciences Inc
- Inspection Date: 2013-04-26
- Product Type: drugs
- Office Name: Division of Inspectional Assessment
- Summary: An FDA inspection of Human Genome Science, Inc.'s drug substance manufacturing facility in Rockville, Maryland, revealed significant deficiencies across multiple systems. Observations included inconsistent manufacturing processes, inadequate endotoxin controls, unvalidated media and buffer hold times, and an ineffective preventive maintenance program. The firm also demonstrated inadequate investigations, insufficient corrective and preventive actions, and a failure to follow or adequately document written procedures.

## Related Documents

- [483 - 2019-03-15](https://www.keypedia.com/records/483/glaxosmithkline-dba-human-genome-sciences-inc/d826d0ff-2abb-4e17-978e-118bec3fad2e)
- [483 - Unknown Date](https://www.keypedia.com/records/483/glaxosmithkline-dba-human-genome-sciences-inc/06180595-cb3e-4947-86f4-5a753f6134fb)
- [483 - 2023-12-11](https://www.keypedia.com/records/483/glaxosmithkline-dba-human-genome-sciences-inc/845ffa38-5805-4d93-95b8-ff8e8d207fcf)
- [483 - 2025-07-31](https://www.keypedia.com/records/483/glaxosmithkline-dba-human-genome-sciences-inc/1bd342b5-73d7-4968-9da2-73fae2cb4d50)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/jee-y-chung/0736677f-9719-44dc-9dab-60b610ac1a0a)
- [Zhihua Qiu](https://www.keypedia.com/people/zhihua-qiu/41771874-d0c3-410b-9042-816cb518101f)
- [Kathy Lea](https://www.keypedia.com/people/kathy-lea/4975e0a1-73fa-48e6-bb62-bcb2ec9371a2)
- [Bo Chi](https://www.keypedia.com/people/bo-chi/9c83477d-58c1-4183-832e-ce8cbd25a521)
- [Nehal Oumer](https://www.keypedia.com/people/nehal-oumer/cdf81798-6008-4ea1-a1a4-f71520c3a825)

Company: https://www.keypedia.com/companies/glaxosmithkline-dba-human-genome-sciences-inc/c3dd2e54-125d-4d56-b0dc-18cb333074cc

Office: https://www.keypedia.com/offices/division-of-inspectional-assessment/9bc7aff2-93a7-404a-8015-0f93c3701c13